William Weiss public CV

William Weiss, MS

Instructor, Pharmaceutical Sciences
UNT System College of Pharmacy

EmailWilliam.Weiss@unthsc.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.

Education/Academic qualification

MS in Biology, Fairleigh Dickinson University

BS in Microbiology, Rutgers University

Fingerprint

Dive into the research topics where William Weiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
17 Finished

TASK X1: THERAPEUTICS TESTING IN MURINE MODELS OF BACTERIAL THIGH AND LUNG INFECTIONS
Weiss, W.
Project: Research
FCCDC 2019-02: Model Development and Test Article Efficacy in a Disseminated Aspergillus and Cutaneous Fungal Infection (Aspergillus & Fusarium) Models
Simecka, J. & Weiss, W.
Fox Chase Chemical Diversity Center, Inc
22/10/19 → 21/10/20
Project: Research
Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus
Simecka, J. & Weiss, W.
Janssen Pharmaceuticals
17/10/19 → 16/10/20
Project: Research
Pre-Clinical Services Agreements
Simecka, J. & Weiss, W.
Pre-Clinical Services Funding Pool
1/09/19 → 31/08/20
Project: Research
Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa
Simecka, J. & Weiss, W.
Janssen Pharmaceuticals
18/04/19 → 17/04/20
Project: Research

2305 Citations
25 h-Index
54 Article
1 Review article

FDA public workshop summary: Advancing animal models for antibacterial drug development
Byrne, J. M., Waack, U., Weinstein, E. A., Joshi, A., Shurland, S. M., Iarikov, D., Bulitta, J. B., Diep, B. A., Guina, T., Hope, W. W., Lawrenz, M. B., Lepak, A. J., Luna, B. M., Miesel, L., Phipps, A. J., Walsh, T. J., Weiss, W., Amini, T. & Farley, J. J., Jan 2021, In: Antimicrobial agents and chemotherapy. 65, 1, e01983-20.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations
C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action
Wu, Z. C., Isley, N. A., Okano, A., Weiss, W. J. & Boger, D. L., 7 Feb 2020, In: Journal of Organic Chemistry. 85, 3, p. 1365-1375 11 p.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- And Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Liu, B., Trout, R. E. L., Chu, G. H., Mcgarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., Benvenuti, M., Mangani, S., Docquier, J. D., Weiss, W. J., Pevear, D. C., Xerri, L. & Burns, C. J., 26 Mar 2020, In: Journal of Medicinal Chemistry. 63, 6, p. 2789-2801 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
44 Scopus citations
In Vivo Efficacy of Novel Monobactam LYS228 in Murine Models of Carbapenemase-Producing Klebsiella pneumoniae Infection
Weiss, W. J., Pulse, M. E., Nguyen, P. & Growcott, E. J., Apr 2019, In: Antimicrobial agents and chemotherapy. 63, 4, e02214-18.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections
Goldmann, O., Cern, A., Muesken, M., Rohde, M., Weiss, W., Barenholz, Y. & Medina, E., 28 Dec 2019, In: Journal of Controlled Release. 316, p. 292-301 10 p.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations